ADDIE SNYDER: Open Payments
NPI 1831616820 · CARENCRO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 40 payments from 11 companies in 2025. Trend: 2023 $1,093 · 2024 $1,068 · 2025 $870
Food & beverage: $870
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $270 |
| Alkermes, Inc. | 13 | $215 |
| Axsome Therapeutics, Inc. | 6 | $102 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Braeburn Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Indivior Inc. | 1 | $24 |
| Neos Therapeutics, LP | 1 | $20 |
Products named: SPRAVATO, ARISTADA, Auvelity, FANAPT, TRINTELLIX, BRIXADI, VRAYLAR, CAPLYTA.
Industry payments across LA — which companies pay providers there.
